Brandi Bratrude is a Program Manager in Stem Cell Transplant at Boston Children's Hospital/Dana-Farber Cancer Institute. With 15 years of clinical research experience, she's worked with many clinical and research teams across the US, Canada and the Caribbean running studies including an investigator-initiated trial that recently went through FDA inspection leading to the approval of the first ever drug for Graft-versus-Host-Disease prophylaxis in patients undergoing stem cell transplant. Brandi enjoys the creativity and collaboration involved in running successful clinical trails and finds purpose in the important work of providing options for patients.